Selling Your Practice to Private Equity: What to Prepare
More and more owners of aesthetic and specialty practices are facing the same situation. A private equity firm approaches them with an interest in buying the business, even if the owner never intended to sell. The call or email comes out of the blue, and the initial reaction is usually one of confusion: where do you even begin this conversation?
The key question is this: what do you actually need to have in order at your practice before a serious discussion about selling a medical practice to private equity can lead anywhere at all? An investor’s interest means nothing on its own if the practice’s finances and documentation aren’t in order. Many owners miss out on the best terms precisely because they only begin preparing to sell their medical practice to private equity after the buyer is already at the negotiating table, rather than in advance.
Why Private Equity Is Buying Medical Practices
An investment fund consolidates several practices into a single, larger structure called a platform. The fund then holds this platform for several years, helps it grow, and eventually sells it in its entirety to the next buyer, often at a profit.
Private equity buying medical practices is particularly active in fields such as plastic surgery, dermatology, and medical spas. The reason is clear: in these specialties, a significant portion of payment comes directly from patients without involving insurance companies, and the business can easily be scaled across multiple locations. According to an industry overview by Sofer Advisors, private equity firms closed 79 deals in the first quarter of 2025 alone, with a particular focus on dermatology, cardiology, orthopedics, and behavioral health, which shows just how active private equity buying medical practices remains in these specific areas.
What are the typical timelines and deal structures? Usually, a fund expects to sell the platform 3-7 years after the acquisition. Practice owners should view private equity in medicine not as a one-time payout and retirement, but as a partnership lasting several years, where they will operate under new conditions and meet new expectations. Understanding this timeframe in advance eliminates much of the disappointment owners feel when they expect to exit the business immediately after signing the documents.
What Makes a Practice Attractive to a Private Equity Buyer
Buyers check a few basic things first. These include having several physicians on staff, stable revenue of $2 million or more, and limited dependence on any one specific specialist. If a practice relies exclusively on a single physician, this poses a serious risk to the fund: what happens to the business if that person leaves or falls ill?
The practice’s operational maturity is also important. This includes a well-organized schedule, standardized documentation, and financial reports that demonstrate steady growth over several years, rather than a single successful year amid general instability. A buyer wants to see a trend, not a random spike in revenue right before the sale.
A practice that positions itself as a serious medical practice investment, rather than simply a small asset that is difficult to scale, typically receives an offer with a higher multiple. According to industry surveys, EBITDA multiples for medical practices in 2025 and 2026 typically range from 6x to 12x and higher, depending on the practice’s size, specialty, and market position. Practices with an EBITDA of more than $5 million typically receive a multiplier that is two to four points higher than smaller practices, which is directly related to how easily such a practice can be scaled further.
Financial and Operational Records to Prepare Before You Sell
The financial documents buyers expect include several key items:
- Three or more years of unaudited financial statements.
- A clear calculation of the EBITDA figure.
- Normalized owner’s compensation, that is, adjusted to account for personal expenses charged to the business.
Operational documentation is no less important:
- Contracts with physicians and other providers.
- Contracts with insurance companies.
- Lease terms for the premises.
- Any outstanding compliance issues or legal proceedings.
Organized data from the practice’s EMR system and scheduling system significantly speeds up the due diligence process and helps avoid unpleasant last-minute surprises. When a buyer asks to see three years’ worth of records, and the data is scattered across paper logs and various software programs, it immediately raises red flags and slows down the deal. That’s why platforms like EmilyEMR, where the entire patient history and schedule are stored in one place, save time at this stage and reduce the risk that the buyer will find data inconsistencies.
How Private Equity Deals Are Typically Structured
A typical deal structure combines cash at closing with equity in a larger platform, tied to the practice’s EBITDA multiple. According to 2026 industry surveys, the equity stake in the platform the owner receives instead of a portion of the cash has risen to 20-40 percent of the transaction value, up from 10-20 percent just a few years ago. This means the owner’s ultimate benefit depends more on how successfully the platform performs in the future than on the amount received at the time of signing.
A typical post-sale obligation looks like this: the owner usually continues to practice for five years or longer under an employment contract with the new entity. Understand this in advance because selling a practice does not mean an immediate departure from the clinic. Some owners expect to leave immediately after the deal closes, and this is one of the most common sources of disappointment during negotiations.
The terms of buying medical practice deals vary widely, and comparing several offers side by side is more important than chasing the highest number in the offer’s headline. A high multiple may hide unfavorable terms regarding equity ownership, the duration of obligations, or contract termination conditions. A practice with a slightly more modest multiple but transparent terms and a reasonable commitment period often proves more profitable in the long run than a medical practice acquisition offer with the largest number on the first page.
What Happens After the Sale
After the transaction, operations shift. The private equity partner typically takes over billing, human resources, marketing, and back-office operations, while the physician retains clinical decision-making. This division is similar to the MSO model we wrote about earlier: business and medicine remain formally separate but work together.
Research also confirms a harsh reality worth knowing in advance. According to a study published in JAMA Health Forum in 2025, physicians in practices that private equity resells to a subsequent buyer are 16.5 percentage points more likely to leave their practice within two years of such a resale compared to similar physicians in practices without private equity involvement. Only 44 percent of physicians remain after the sale, compared to 60 percent in comparable practices without private equity involvement. This means the initial retention incentives the fund offers at the time of purchase weaken over time, especially as the next resale approaches.
This is why it is important to obtain written guarantees in advance on several issues: the physician’s clinical autonomy, who makes decisions about staff hiring, and what will happen when the platform is sold again in a few years. Verbal promises made during negotiations rarely match reality five years later, and in private equity medicine, the fund’s and the physician’s interests don’t always align over the next few years.
Preparation Determines the Outcome
The strongest offers usually go to practices that have gotten their finances and operational processes in order long before the first buyer appears. Rushing the deal is almost always noticeable and drives down the offer price. Practices that prepare in advance, rather than reacting to incoming interest in a panic, typically better understand the real conditions of private equity medicine and negotiate from a stronger position.
To briefly recap the entire checklist: clean financial statements, several doctors on staff, clarity on EBITDA, and a clear understanding of what the practice’s future will look like after the sale. Each of these points directly affects the final medical practice investment valuation and the terms you’ll actually be able to negotiate with the buyer, rather than simply accepting whatever is offered.
It’s worth getting the practice’s financial and clinical data in order now, regardless of how close you are to a sale. Platforms like EmilyEMR help keep this data organized from the start, rather than forcing you to sort it out in a rush a month before due diligence.